We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Draft Pharma Policy 2017 which was released for comments in mid-August, has an ambitious intent: to make drug pricing ‘more poor oriented while retaining its industry friendliness’.